Compounds > cilostazol

cilostazol and monocrotaline

cilostazol has been researched along with monocrotaline in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, LT; Chiang, CH; Lee, FY; Sheu, JJ; Sun, CK; Wu, CJ; Yip, HK; Youssef, AA1
Chai, HT; Chang, LT; Chen, YT; Chua, S; Chung, SY; Kao, YH; Lee, FY; Sheu, JJ; Sun, CK; Yip, HK; Yuen, CM1
Fushida, S; Harada, SI; Hayashi, H; Hirata, M; Iseki, S; Makino, I; Miyashita, T; Miyata, T; Nakanuma, SI; Ninomiya, I; Ohta, T; Oyama, K; Tajima, H; Takamura, H; Wakayama, T1

Other Studies

3 other study(ies) available for cilostazol and monocrotaline

ArticleYear
Cilostazol therapy attenuates monocrotaline-induced pulmonary arterial hypertension in rat model.
    Circulation journal : official journal of the Japanese Circulation Society, 2008, Volume: 72, Issue:5

    Topics: Animals; Blood Pressure; Body Weight; Cilostazol; Connexin 43; Disease Models, Animal; Endothelium, Vascular; Gene Expression; Hypertension, Pulmonary; Male; Monocrotaline; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Pulmonary Alveoli; Rats; Rats, Sprague-Dawley; Tetrazoles; Vasodilator Agents

2008
Early combined treatment with cilostazol and bone marrow-derived endothelial progenitor cells markedly attenuates pulmonary arterial hypertension in rats.
    The Journal of pharmacology and experimental therapeutics, 2009, Volume: 330, Issue:3

    Topics: Animals; Bone Marrow Transplantation; Cilostazol; Combined Modality Therapy; Endothelial Cells; Fluorescent Dyes; Hematopoietic Stem Cell Transplantation; Hemodynamics; Hypertension, Pulmonary; Lung; Male; Membrane Proteins; Monocrotaline; Myocardium; Phenotype; Poisons; Pulmonary Alveoli; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Tetrazoles; Vasodilator Agents

2009
Phosphodiesterase III inhibitor attenuates rat sinusoidal obstruction syndrome through inhibition of platelet aggregation in Disse's space.
    Journal of gastroenterology and hepatology, 2018, Volume: 33, Issue:4

    Topics: Animals; Antigens, CD34; Capillaries; Cilostazol; Disease Models, Animal; Epithelial Cells; Hepatic Veno-Occlusive Disease; Liver; Male; Monocrotaline; Phosphodiesterase 3 Inhibitors; Plasminogen Activator Inhibitor 1; Platelet Aggregation; Platelet Membrane Glycoprotein IIb; Rats, Wistar; Tetrazoles; Time Factors

2018